These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 20556340)
1. [Hypertension as a biological marker of systemic atherosclerotic disease]. Román A O; Badilla S M; Dussaubat A AM Rev Med Chil; 2010 Mar; 138(3):346-51. PubMed ID: 20556340 [TBL] [Abstract][Full Text] [Related]
2. Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise. von Känel R; Hong S; Pung MA; Mills PJ Am J Hypertens; 2007 Jun; 20(6):670-5. PubMed ID: 17531926 [TBL] [Abstract][Full Text] [Related]
4. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197 [TBL] [Abstract][Full Text] [Related]
6. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
8. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Tayama J; Munakata M; Yoshinaga K; Toyota T Hypertens Res; 2006 Jun; 29(6):403-9. PubMed ID: 16940702 [TBL] [Abstract][Full Text] [Related]
9. Cerebral consequences of hypertension: where do they lead? Spence JD J Hypertens Suppl; 1996 Dec; 14(5):S139-45. PubMed ID: 9120671 [TBL] [Abstract][Full Text] [Related]
10. Cugini's syndrome: a new cardiovascular entity. Interview by G. M. Fara. Cugini P Ann Ig; 2009; 21(3):189-95. PubMed ID: 19798897 [TBL] [Abstract][Full Text] [Related]
11. [Atherosclerosis as a systemic disease]. Lahoz C; Mostaza JM Rev Esp Cardiol; 2007 Feb; 60(2):184-95. PubMed ID: 17338883 [TBL] [Abstract][Full Text] [Related]
12. Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Chi YW; Jaff MR Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227 [TBL] [Abstract][Full Text] [Related]
13. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R; Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141 [TBL] [Abstract][Full Text] [Related]
14. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Schiffrin EL Am J Hypertens; 2004 Dec; 17(12 Pt 2):39S-48S. PubMed ID: 15607434 [TBL] [Abstract][Full Text] [Related]
16. Male gender and not the severity of hypertension is associated with end-organ damage in aged stroke-prone spontaneously hypertensive rats. Masineni SN; Chander PN; Singh GD; Powers CA; Stier CT Am J Hypertens; 2005 Jun; 18(6):878-84. PubMed ID: 15925751 [TBL] [Abstract][Full Text] [Related]
17. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Wong TY; McIntosh R Br Med Bull; 2005; 73-74():57-70. PubMed ID: 16148191 [TBL] [Abstract][Full Text] [Related]
18. Human urotensin II as a link between hypertension and coronary artery disease. Watanabe T; Kanome T; Miyazaki A; Katagiri T Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699 [TBL] [Abstract][Full Text] [Related]
19. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Jensen JS Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799 [TBL] [Abstract][Full Text] [Related]
20. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Chapman MJ; Sposito AC Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]